TrialRadiation oncology (London, England)2025

Phase II clinical trial assessing the addition of hyperthermia to salvage concurrent chemoradiotherapy for unresectable recurrent head and neck cancer in previously irradiated patients.

Kai-Lin Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.